Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Pharm Biomed Anal ; 149: 278-289, 2018 Feb 05.
Article in English | MEDLINE | ID: mdl-29128828

ABSTRACT

Quantitative evaluation and assessment of pharmacokinetic parameters of Diprospan® (suspension for injection 7mg/mL (2mg+5mg/mL) of betamethasone) were performed in urine samples taken from patients with rheumatoid arthritis or ankylosing spondylitis for 28days after systemic intramuscular administration in routine clinical practice in an open-comparative prospective cohort study. The maximum betamethasone concentration was reached at day 4 of the follow-up; in some cases, ß-phase of elimination of the drug was appeared at day 14 or at day 21 of the follow-up. The deferred ß-phase elimination was likely a consequence of the physiological characteristics of the patients or of the influence of non-steroidal agents. The half-life of betamethasone was 8.5days. The elimination rate constant was 2.49h-1; the mean clearance was 4.72L/d. The recommended frequency of the drug administration to its complete elimination was estimated up to 48days. Mann-Whitney test showed no significant differences in pharmacokinetic characteristics between male and female subjects. The prolonged elimination phase was observed in patients with deviations in their body mass index, continual treatment by diclofenac and nimesulide or, possibly, after consuming an alcohol. The study was recorded in Clinical Trials open source with identifier NCT03119454.


Subject(s)
Arthritis, Rheumatoid/drug therapy , Betamethasone/analogs & derivatives , Glucocorticoids/pharmacokinetics , Renal Elimination/drug effects , Spondylitis, Ankylosing/drug therapy , Adult , Arthritis, Rheumatoid/urine , Betamethasone/administration & dosage , Betamethasone/pharmacokinetics , Betamethasone/urine , Diclofenac/pharmacology , Drug Combinations , Ethanol/pharmacology , Female , Glucocorticoids/administration & dosage , Glucocorticoids/urine , Half-Life , Humans , Injections, Intramuscular , Male , Prospective Studies , Sex Factors , Spondylitis, Ankylosing/urine , Sulfonamides/pharmacology
2.
Beilstein J Nanotechnol ; 8: 2552-2561, 2017.
Article in English | MEDLINE | ID: mdl-29259870

ABSTRACT

We study the unwinding of the ferrocholesteric helical structure induced by a combined action of a magnetic field and a shear flow. Both influences are able to induce the ferrocholesteric-ferronematic transition independently; however, the differences between the magnetic field orientation and the flow alignment direction lead to a competition between magnetic and hydrodynamic mechanisms of influence on the ferrocholesteric structure. We analyze various orientations of a magnetic field relative to the direction of a shear flow. The pitch of the ferrocholesteric helix is obtained as function of the strength and the orientation angle of the magnetic field, the shear velocity gradient and a reactive parameter. Phase diagrams of ferrocholesteric-ferronematic transition and the pitch of the ferrocholesteric helix as functions of the material and the governing parameters are calculated. We find out that imposing a shear flow leads to a shift of the magnetic field threshold. The value of the critical magnetic field depends on the magnetic field orientation, the velocity gradient, and the viscous coefficients. We show that the interplay of a magnetic field and a shear flow can induce reentrant orientational transitions that are ferrocholesteric-ferronematic-ferrocholesteric.

3.
J Biol Inorg Chem ; 22(1): 153-160, 2017 01.
Article in English | MEDLINE | ID: mdl-27878396

ABSTRACT

Dinitrosyl iron complexes (DNICs) are physiological NO derivatives and account for many NO functions in biology. Polyfunctional dipeptide carnosine (beta-alanyl-L-histidine) is considered to be a very promising pharmacological agent. It was shown that in the system containing carnosine, iron ions and Angeli's salt, a new type of DNICs bound with carnosine as ligand {(carnosine)2-Fe-(NO)2}, was formed. We studied how the carbonyl compound methylglyoxal influenced this process. Carnosine-bound DNICs appear to be one of the cell's adaptation mechanisms when the amount of reactive carbonyl compounds increases at hyperglycemia. These complexes can also participate in signal and regulatory ways of NO and can act as protectors at oxidative and carbonyl stress conditions.


Subject(s)
Carnosine/metabolism , Iron/metabolism , Nitrogen Oxides/metabolism , Iron/chemistry , Nitrogen Oxides/chemistry , Protein Binding/drug effects , Pyruvaldehyde/pharmacology
4.
J Korean Med Sci ; 31(2): 202-7, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26839473

ABSTRACT

The aim of the study was to examine lipid profiles, arterial stiffness (AS), carotid intima-media thickness (cIMT), in 55 women with RA without overt cardiovascular disease (СVD) treated with rituximab (RTX).The following parameters were recorded before and 24 weeks after RTX therapy (2 infusions of 500 or 1,000 mg RTX intravenously, fortnightly): plasma total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglycerides, DAS 28-ESR, serum C-reactive protein (CRP), RF IgM, AS (SI - stiffness index, RI - reflection index) by digital volume pulse contour analysis (Micro Medical, UK), and common cIMT by high-resolution B-mode carotid ultrasound. Based on the European League Against Rheumatism (EULAR) criteria, patients were divided into two groups: 1) moderate/good response to RTX therapy after 24 weeks (41 patients, 75%), 2) no response to RTX therapy (14 patients, 25%). Effective RTX therapy resulted in 9% increase in TC, 23% increase in HDL-C and 14% decrease in atherogenic index, 57% decrease in SI and 24% decrease in RI. We observed a 9% decrease of cIMTmax at 24 weeks. The improvement of cardiovascular parameters was accompanied by statistically significant decreases of CRP, ESR, RF IgM and DAS 28 in group 1 (P < 0.05). There were not significant changes in lipid profile, AS parameters, and cIMT in group 2. Two infusions of RTX in case of moderate/good EULAR effect of therapy exerted favorable effects on lipid profile, AS and cIMT in women with RA without overt CVD.


Subject(s)
Antirheumatic Agents/therapeutic use , Arthritis, Rheumatoid/drug therapy , Lipids/blood , Rituximab/therapeutic use , Arthritis, Rheumatoid/complications , Arthritis, Rheumatoid/physiopathology , Biomarkers/blood , C-Reactive Protein/analysis , Cardiovascular Diseases/complications , Carotid Intima-Media Thickness , Cholesterol, HDL/blood , Cholesterol, LDL/blood , Female , Humans , Middle Aged , Treatment Outcome , Triglycerides/blood , Vascular Stiffness
5.
J Med Chem ; 45(4): 805-17, 2002 Feb 14.
Article in English | MEDLINE | ID: mdl-11831893

ABSTRACT

A new series of short pyrrole tetraamides are described whose submicromolar DNA binding affinity is an essential component for their strong antibacterial activity. This class of compounds is related to the linked bis-netropsins and bis-distamycins, but here, only one amino-pyrrole-carboxamide unit and an amidine tail is connected to either side of a central dicarboxylic acid linker. The highest degree of DNA binding, measured by compound-induced changes in UV melting temperatures of an AT-rich DNA oligomer, was observed for flat, aromatic linkers with no inherent bent, i.e., terephthalic acid or 1,4-pyridine-dicarboxylic acid. However, the antibacterial activity is critically linked to the size of the N-alkyl substiutent of the pyrrole unit. None of the tetraamides with the commonly used methyl-pyrrole showed antibacterial activity. Isoamyl- or cyclopropylmethylene-substituted dipyrrole derivatives have the minimum inhibitory concentrations in the submicromolar range. In vitro toxicity against human T-cells was studied for all compounds. The degree to which compounds inhibited cell growth was neither directly correlated to DNA binding affinity nor directly correlated to antibacterial activity but seemed to depend strongly on the nature of the N-alkyl pyrrole substituents.


Subject(s)
Amides/chemical synthesis , Anti-Bacterial Agents/chemical synthesis , DNA/chemistry , Enterococcus/drug effects , Pyrroles/chemical synthesis , Staphylococcus aureus/drug effects , Amides/chemistry , Amides/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/pharmacology , Humans , Methicillin Resistance , Microbial Sensitivity Tests , Models, Molecular , Pyrroles/chemistry , Pyrroles/pharmacology , Structure-Activity Relationship , T-Lymphocytes/drug effects , Tumor Cells, Cultured , Vancomycin Resistance
SELECTION OF CITATIONS
SEARCH DETAIL
...